NGS Based RNA Seq Market Share, Size, and Outlook by 2031
NGS Based RNA Seq Market: Strategic Insights
NGS Based RNA Seq Market
-
CAGR (2023 - 2031)9.32% -
Market Size 2023
US$ 3.25 Billion -
Market Size 2031
US$ 13.35 Billion
Market Dynamics
GROWTH DRIVERS
- Declining Cost of Genome Sequencing Raises Demand for NGS Based RNA Seq Technologies
FUTURE TRENDS
- Developments in RNA Sequencing Technologies
OPPORTUNITIES
- Expanding Applications of NGS in Oncology and Precision Medicine Brings Growth Opportunities in NGS Based RNA Seq Market
Key Players
- Illumina Inc
- PerkinElmer Inc
- F Hoffmann La Roche Ltd
- QIAGEN N V
- Agilent Technologies Inc
- Thermo Fisher Scientific Inc
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc
- BGI
- Eurofins Scientific
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product & Services
- Sample Preparation
- Sequencing Services
- Sequencing Platform & Consumables and Data Analysis
- Storage & Management
Technology
- Sequencing Synthesis
- Nanopore Sequencing
- Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing
Application
- Diagnostics
- Drug Discovery
- Precision Medicine
End User
- Biotechnology & Pharmaceutical Companies
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes